Description
Developmental therapeutics at ESMO 2014
Article: Developmental therapeutics at ESMO 2014
€2.42
Related products
-
Article: Calendar of events
€2.42 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€2.42 Add to cart
Reviews
There are no reviews yet.